Cargando…
GLP-1 Receptor Agonists: Nonglycemic Clinical Effects in Weight Loss and Beyond
OBECTIVE: Glucagon-like peptide-1 (GLP-1) receptor agonists are indicated for treatment of type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet cells, stimulating insulin release, while inhibiting glucagon release, in a glucose-dependent manner. The observation of weight...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692091/ https://www.ncbi.nlm.nih.gov/pubmed/25959380 http://dx.doi.org/10.1002/oby.21107 |